Live
- RED Health leads critical care in a nation missing timely emergency aid for 80% of patients
- Amazon.in Partners with NCERT to Make K-12 Books Available Pan India
- Maruti Suzuki launches Grand Vitara Dominion Edition: Where distinctive style meets dominance
- UDF Moves Adjournment Motion Over Senior Police Officer's Alleged Meeting With RSS Leaders
- National Conference holds upper hand in J&K alliance as Congress performance below par
- BJP won nearly 2/3 seats it contested in J&K: Assam CM
- Shanghai Masters: Djokovic remains on course for100th tour-level title with win over Cobolli
- PM Modi compliments NC for its victory in J&K polls
- Fan murder case: Hearing on Kannada superstar Darshan's bail plea adjourned to Oct 9
- Kolkata CBI court denies bail to Kuntal Ghosh in teacher recruitment scam
Dr Reddy’s unveils anti-cholesterol drugs in United States
Dr Reddy\'s Laboratories on Tuesday said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
Hyderabad: Dr Reddy's Laboratories on Tuesday said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
The city-based drug maker has launched Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg in the US market following approval from the US Food and Drug Administration, the company said in a statement.
They are available in bottle count sizes of 30, 90 and 1000. The drug is a therapeutic equivalent generic version of Vytorin (Ezetimibe and Simvastatin) tablets and Dr Reddy’s is among the first companies to launch the generic product in the US market.
Vytorin which is indicated for use along with a healthy diet to reduce elevated LDL cholesterol in patients with hyperlipidemia is registered trademark of MSD International GMBH.
The Vytorin brand had US sales of approximately $678 million MAT (Moving Annual Total) for the most recent twelve months ended in February 2017, according to IMS Health.
